The largest database of trusted experimental protocols

Cacl2 solution

Manufactured by Siemens
Sourced in Germany

CaCl2 solution is a laboratory reagent that consists of a water-based solution containing calcium chloride (CaCl2). It is a colorless, odorless liquid that is commonly used in various scientific and industrial applications.

Automatically generated - may contain errors

4 protocols using cacl2 solution

1

Coagulation Time Measurement in Human Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coagulation times were determined in human plasma using a STAGO STart 4 coagulation analyzer (Diagnostica). Human single donor plasma was used (Innovative Research). For the extrinsic coagulation, 50 μl of plasma with or without inhibitor was placed in the incubating chamber of the instrument for 2 min at 37°C. After incubation, 100 μl of innovin (recombinant human tissue factor, synthetic phospholipids, and calcium in stabilized Hepes buffer system; Dade Behring/Siemens) was added using the pipet connected to the instrument. Upon addition of this reagent, the electromagnetically induced movement of a steel ball in the plasma was monitored. The time until the ball stops moving was recorded as coagulation time. For the intrinsic coagulation, 100 μl of plasma with or without inhibitor was incubated with 100 μl of Pathromtin SL (silicon dioxide particles and plant phospholipids in Hepes buffer system, Siemens) for 2 min at 37°C. Subsequently, the coagulation was triggered by addition of 100 μl of CaCl2 solution (25 mM, Siemens).
+ Open protocol
+ Expand
2

Activated Partial Thromboplastin Time Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activated partial thromboplastin time was measured on a STart4 coagulation analyser (Diagnostica Stago). One hundred microlitre of rabbit plasma was incubated at 37 °C with 100 μl of Dade/Actin (contains phospholipids from rabbit brain and ellagic acid, Siemens) for 3 min. One hundred microlitre of human plasma was incubated at 37 °C with 100 μl of Pathromtin* SL (silicon dioxide particles, plant phospholipids in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer system, Siemens) for 2 min. Coagulation was triggered by addition of 100 μl of CaCl2 solution (25 mM; Siemens). The time to coagulation was assessed by monitoring the movement of a steel ball in the plasma.
+ Open protocol
+ Expand
3

Activated Partial Thromboplastin Time Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activated partial thromboplastin time (aPTT) was determined using a semiautomatic coagulation analyzer (BFT II, Siemens) and recommended reagents, including platelet poor plasma (PPP; Control Plasma P, Siemens), aPTT reagent (Actin FSL, Siemens) and 0.2 M calcium chloride (CaCl2 solution, Siemens). Solutions of NMFs at concentrations of 25 mg ml−1 were prepared and vortexed for 30 s. All test samples (n = 5 per composition), cuvettes and test reagents were incubated at 37°C. Next, 50 μl of PPP and 50 μl of NMF solution were added to the cuvette and incubated at 37°C for 3 min. Finally, 50 μl of CaCl2 were added after incubation. As soon as clotting was detected, the clotting time was displayed and recorded. PPP and aPTT reagent were used as negative control. Arista hemostatic agent was used as positive control. Standard reagents and control plasma were used to establish control aPTT.
+ Open protocol
+ Expand
4

Vitamin K Assay Standards and Coagulation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vitamin K1 standard substance (99.6%) and vitamin K2 standard substance (99.9%) were supplied by National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China) and Supelco (Bellefonte, USA) respectively. Vitamin K1 injection was from Cisen Pharmaceutical Co. (Shandong, China). Rat PIVKA-II ELISA kits and D-Dimer ELISA kits were purchased from KeyGENBioTECH (Nanjing, China). Prothrombin time (PT), activated partial thromboplastin time (APTT), FII, FVII, FIX, FX, CaCl 2 solution and human standard plasma reagents were obtained from Siemens Healthcare Diagnostics Products GmbH (Marburg, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!